TERF2 and atherosclerosis: Studies using transgenic mice have shown that VSMC-specific loss of TRF2 function increases atherosclerosis and necrotic core formation in vivo, while these pathological changes are suppressed in mice with VSMC-specific gain of TRF2 function (87).